1 Study Coverage
1.1 Lung Cancer Liquid Biops Revenue in Lung Cancer Liquid Biops Business (2017-2022) & (US$ Million) Introduction
1.2 Global Lung Cancer Liquid Biops Outlook 2017 VS 2022 VS 2028
1.2.1 Global Lung Cancer Liquid Biops Market Size for the Year 2017-2028
1.2.2 Global Lung Cancer Liquid Biops Market Size for the Year 2017-2028
1.3 Lung Cancer Liquid Biops Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.3.1 The Market Share of United States Lung Cancer Liquid Biops in Global, 2017 VS 2022 VS 2028
1.3.2 The Growth Rate of Lung Cancer Liquid Biops Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4 Lung Cancer Liquid Biops Market Dynamics
1.4.1 Lung Cancer Liquid Biops Industry Trends
1.4.2 Lung Cancer Liquid Biops Market Drivers
1.4.3 Lung Cancer Liquid Biops Market Challenges
1.4.4 Lung Cancer Liquid Biops Market Restraints
1.5 Study Objectives
1.6 Years Considered
2 Lung Cancer Liquid Biops by Type
2.1 Lung Cancer Liquid Biops Market Segment by Type
2.1.1 Exosomes and RNA
2.1.2 CTCs and ctDNA
2.2 Global Lung Cancer Liquid Biops Market Size by Type (2017, 2022 & 2028)
2.3 Global Lung Cancer Liquid Biops Market Size by Type (2017-2028)
2.4 United States Lung Cancer Liquid Biops Market Size by Type (2017, 2022 & 2028)
2.5 United States Lung Cancer Liquid Biops Market Size by Type (2017-2028)
3 Lung Cancer Liquid Biops by Application
3.1 Lung Cancer Liquid Biops Market Segment by Application
3.1.1 Hospitals and Clinics
3.1.2 Physicians'Office Laboratories
3.1.3 Clinical Diagnostic Laboratories
3.2 Global Lung Cancer Liquid Biops Market Size by Application (2017, 2022 & 2028)
3.3 Global Lung Cancer Liquid Biops Market Size by Application (2017-2028)
3.4 United States Lung Cancer Liquid Biops Market Size by Application (2017, 2022 & 2028)
3.5 United States Lung Cancer Liquid Biops Market Size by Application (2017-2028)
4 Global Lung Cancer Liquid Biops Competitor Landscape by Company
4.1 Global Lung Cancer Liquid Biops Market Size by Company
4.1.1 Top Global Lung Cancer Liquid Biops Companies Ranked by Revenue (2021)
4.1.2 Global Lung Cancer Liquid Biops Revenue by Player (2017-2022)
4.2 Global Lung Cancer Liquid Biops Concentration Ratio (CR)
4.2.1 Lung Cancer Liquid Biops Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Companies of Lung Cancer Liquid Biops in 2021
4.2.3 Global Lung Cancer Liquid Biops Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Lung Cancer Liquid Biops Headquarters, Revenue in Lung Cancer Liquid Biops Business (2017-2022) & (US$ Million) Type
4.3.1 Global Lung Cancer Liquid Biops Headquarters and Area Served
4.3.2 Global Lung Cancer Liquid Biops Companies Revenue in Lung Cancer Liquid Biops Business (2017-2022) & (US$ Million) Type
4.3.3 Date of International Companies Enter into Lung Cancer Liquid Biops Market
4.4 Companies Mergers & Acquisitions, Expansion Plans
4.5 United States Lung Cancer Liquid Biops Market Size by Company
4.5.1 Top Lung Cancer Liquid Biops Players in United States, Ranked by Revenue (2021)
4.5.2 United States Lung Cancer Liquid Biops Revenue by Players (2020, 2021 & 2022)
5 Global Lung Cancer Liquid Biops Market Size by Region
5.1 Global Lung Cancer Liquid Biops Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Lung Cancer Liquid Biops Market Size by Region (2017-2028)
5.2.1 Global Lung Cancer Liquid Biops Market Size by Region: 2017-2022
5.2.2 Global Lung Cancer Liquid Biops Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Lung Cancer Liquid Biops Market Size YoY Growth 2017-2028
6.1.2 North America Lung Cancer Liquid Biops Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Lung Cancer Liquid Biops Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Lung Cancer Liquid Biops Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Lung Cancer Liquid Biops Market Size YoY Growth 2017-2028
6.3.2 Europe Lung Cancer Liquid Biops Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Lung Cancer Liquid Biops Market Size YoY Growth 2017-2028
6.4.2 Latin America Lung Cancer Liquid Biops Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Lung Cancer Liquid Biops Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Lung Cancer Liquid Biops Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 UAE
7 Company Profiles
7.1 Biocept
7.1.1 Biocept Company Details
7.1.2 Biocept Business Overview
7.1.3 Biocept Lung Cancer Liquid Biops Introduction
7.1.4 Biocept Revenue in Lung Cancer Liquid Biops Business (2017-2022)
7.1.5 Biocept Recent Development
7.2 EntroGen
7.2.1 EntroGen Company Details
7.2.2 EntroGen Business Overview
7.2.3 EntroGen Lung Cancer Liquid Biops Introduction
7.2.4 EntroGen Revenue in Lung Cancer Liquid Biops Business (2017-2022)
7.2.5 EntroGen Recent Development
7.3 Cynvenio Biosystems
7.3.1 Cynvenio Biosystems Company Details
7.3.2 Cynvenio Biosystems Business Overview
7.3.3 Cynvenio Biosystems Lung Cancer Liquid Biops Introduction
7.3.4 Cynvenio Biosystems Revenue in Lung Cancer Liquid Biops Business (2017-2022)
7.3.5 Cynvenio Biosystems Recent Development
7.4 Exosome Diagnostics
7.4.1 Exosome Diagnostics Company Details
7.4.2 Exosome Diagnostics Business Overview
7.4.3 Exosome Diagnostics Lung Cancer Liquid Biops Introduction
7.4.4 Exosome Diagnostics Revenue in Lung Cancer Liquid Biops Business (2017-2022)
7.4.5 Exosome Diagnostics Recent Development
7.5 F. Hoffmann-La Roche
7.5.1 F. Hoffmann-La Roche Company Details
7.5.2 F. Hoffmann-La Roche Business Overview
7.5.3 F. Hoffmann-La Roche Lung Cancer Liquid Biops Introduction
7.5.4 F. Hoffmann-La Roche Revenue in Lung Cancer Liquid Biops Business (2017-2022)
7.5.5 F. Hoffmann-La Roche Recent Development
7.6 Clearbridge BioMedics
7.6.1 Clearbridge BioMedics Company Details
7.6.2 Clearbridge BioMedics Business Overview
7.6.3 Clearbridge BioMedics Lung Cancer Liquid Biops Introduction
7.6.4 Clearbridge BioMedics Revenue in Lung Cancer Liquid Biops Business (2017-2022)
7.6.5 Clearbridge BioMedics Recent Development
7.7 Bio-Rad Laboratories
7.7.1 Bio-Rad Laboratories Company Details
7.7.2 Bio-Rad Laboratories Business Overview
7.7.3 Bio-Rad Laboratories Lung Cancer Liquid Biops Introduction
7.7.4 Bio-Rad Laboratories Revenue in Lung Cancer Liquid Biops Business (2017-2022)
7.7.5 Bio-Rad Laboratories Recent Development
7.8 Agena Bioscience
7.8.1 Agena Bioscience Company Details
7.8.2 Agena Bioscience Business Overview
7.8.3 Agena Bioscience Lung Cancer Liquid Biops Introduction
7.8.4 Agena Bioscience Revenue in Lung Cancer Liquid Biops Business (2017-2022)
7.8.5 Agena Bioscience Recent Development
7.9 Cancer Genetics
7.9.1 Cancer Genetics Company Details
7.9.2 Cancer Genetics Business Overview
7.9.3 Cancer Genetics Lung Cancer Liquid Biops Introduction
7.9.4 Cancer Genetics Revenue in Lung Cancer Liquid Biops Business (2017-2022)
7.9.5 Cancer Genetics Recent Development
7.10 CellMax Life
7.10.1 CellMax Life Company Details
7.10.2 CellMax Life Business Overview
7.10.3 CellMax Life Lung Cancer Liquid Biops Introduction
7.10.4 CellMax Life Revenue in Lung Cancer Liquid Biops Business (2017-2022)
7.10.5 CellMax Life Recent Development
7.11 Nateras
7.11.1 Nateras Company Details
7.11.2 Nateras Business Overview
7.11.3 Nateras Lung Cancer Liquid Biops Introduction
7.11.4 Nateras Revenue in Lung Cancer Liquid Biops Business (2017-2022)
7.11.5 Nateras Recent Development
7.12 MedGenome
7.12.1 MedGenome Company Details
7.12.2 MedGenome Business Overview
7.12.3 MedGenome Lung Cancer Liquid Biops Introduction
7.12.4 MedGenome Revenue in Lung Cancer Liquid Biops Business (2017-2022)
7.12.5 MedGenome Recent Development
7.13 OncoDNA
7.13.1 OncoDNA Company Details
7.13.2 OncoDNA Business Overview
7.13.3 OncoDNA Lung Cancer Liquid Biops Introduction
7.13.4 OncoDNA Revenue in Lung Cancer Liquid Biops Business (2017-2022)
7.13.5 OncoDNA Recent Development
7.14 Genomic Health
7.14.1 Genomic Health Company Details
7.14.2 Genomic Health Business Overview
7.14.3 Genomic Health Lung Cancer Liquid Biops Introduction
7.14.4 Genomic Health Revenue in Lung Cancer Liquid Biops Business (2017-2022)
7.14.5 Genomic Health Recent Development
7.15 Trovagene
7.15.1 Trovagene Company Details
7.15.2 Trovagene Business Overview
7.15.3 Trovagene Lung Cancer Liquid Biops Introduction
7.15.4 Trovagene Revenue in Lung Cancer Liquid Biops Business (2017-2022)
7.15.5 Trovagene Recent Development
7.16 Fluxion Biosciences
7.16.1 Fluxion Biosciences Company Details
7.16.2 Fluxion Biosciences Business Overview
7.16.3 Fluxion Biosciences Lung Cancer Liquid Biops Introduction
7.16.4 Fluxion Biosciences Revenue in Lung Cancer Liquid Biops Business (2017-2022)
7.16.5 Fluxion Biosciences Recent Development
7.17 Biodesix
7.17.1 Biodesix Company Details
7.17.2 Biodesix Business Overview
7.17.3 Biodesix Lung Cancer Liquid Biops Introduction
7.17.4 Biodesix Revenue in Lung Cancer Liquid Biops Business (2017-2022)
7.17.5 Biodesix Recent Development
7.18 Epic Sciences
7.18.1 Epic Sciences Company Details
7.18.2 Epic Sciences Business Overview
7.18.3 Epic Sciences Lung Cancer Liquid Biops Introduction
7.18.4 Epic Sciences Revenue in Lung Cancer Liquid Biops Business (2017-2022)
7.18.5 Epic Sciences Recent Development
7.19 Shuwen Biotech
7.19.1 Shuwen Biotech Company Details
7.19.2 Shuwen Biotech Business Overview
7.19.3 Shuwen Biotech Lung Cancer Liquid Biops Introduction
7.19.4 Shuwen Biotech Revenue in Lung Cancer Liquid Biops Business (2017-2022)
7.19.5 Shuwen Biotech Recent Development
7.20 Personal Genome Diagnostics
7.20.1 Personal Genome Diagnostics Company Details
7.20.2 Personal Genome Diagnostics Business Overview
7.20.3 Personal Genome Diagnostics Lung Cancer Liquid Biops Introduction
7.20.4 Personal Genome Diagnostics Revenue in Lung Cancer Liquid Biops Business (2017-2022)
7.20.5 Personal Genome Diagnostics Recent Development
7.21 Predicine
7.21.1 Predicine Company Details
7.21.2 Predicine Business Overview
7.21.3 Predicine Lung Cancer Liquid Biops Introduction
7.21.4 Predicine Revenue in Lung Cancer Liquid Biops Business (2017-2022)
7.21.5 Predicine Recent Development
8 Research Findings and Conclusion
9 Appendix
9.1 Research Methodology
9.1.1 Methodology/Research Approach
9.1.2 Data Source
9.2 Author Details
9.3 Disclaimer
